Sumitomo Chemical stock
4005.TJPXSumitomo Chemical Company, Limited, Basic MaterialsISIN JP3401400001
54Score 54 out of 100, Neutral
Price and trend
52 / 100
Price history
+16% in one yearThe chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Below the 200-day line: the price is 4.0% below it.
Since August 2025 the 50-day line has been above the 200-day line; the trend has turned up.
Normal: the price is neither overheated nor sold off (RSI 36).
The price is 17% below its 52-week high. Largest decline in 20 years: 82% (November 2007 to October 2012).
Chart figures for advanced users
- SMA 50$3.57
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$3.39
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)36
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDbelow the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$2.69
- The lowest closing price of the last twelve months.
- Resistance$3.92
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Sumitomo Chemical Company, Limited belongs to the Chemicals (Specialty) industry (Japan) and, with a market value of $5.42B, is number 60 of 106 companies in its industry on MEQIRI.
- In fiscal 2026 it reported revenue of $14.58B (down 10.7% year on year) and earnings of $381.64M (up 57.9%).
- For fiscal 2027, analysts expect on average revenue of $15.48B (up 6.2%) and adjusted earnings per share of $0.43 (up 84.9%).
Show more
- MEQIRI Score 54 out of 100 (Neutral): rank 266 of 461 in Basic Materials, median 57.
- The P/E is 8.3 (Chemicals (Specialty) median 22.5, own median of recent years 13.4).
- Our model puts fair value at $7.16, with the price 54% below it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Modestly valuedP/E 8.3, Chemicals (Specialty) median 22.5, own median 13.4.Valuation 82
- Below fair valuePrice 54% below the fair value of $7.16.Valuation 82
- Earnings turn into cashFree cash flow 117% of earnings over the last 12 months.Fundamentals 68
Weaknesses
- Interest barely coveredOperating profit covers interest only 2.8 times.Stability 59
Its standout strength is valuation, while growth and profitability hold the score back.
Daily figure as of 13 Nov 2026
How the score is calculatedScore overview
Score since yesterday from 53 to 54.
The fundamentals are in the middle range.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk not measured
How well MEQIRI warnsFor stocks from Japan, China, Hong Kong, Taiwan, Korea, Canada, India and Brazil we only show crash risk once a separate backtest shows that it warns as well there as in the US and Europe.
Valuation
Valuation signal
Significantly undervaluedIn our model the price counts as cheap below $5.11 and expensive above $11.93 (uncertainty high, based on the price swings of the past year).
The two parts of the fair value come to $5.47 (cash-flow model) and $8.85 (industry comparison), and the gap between them shows how uncertain the estimate is. The price is below both.
Calculated with a cost of equity of 9.1%. At 10.1% the fair value would be $6.88, at 8.1% it would be $7.52.
Valuation metrics
Half from the cash-flow model, half from earnings times the industry P/E (22.5).
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the twelve months to 30 Sep 2026, revenue fell 2.2% on the twelve months before. Revenue has stayed largely stable since 2007.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2026: gross 29%, operating 4%, net 3%.
Debt & balance sheet
latest quarterDebt is moderate, but interest coverage is weak. Keep an eye on the interest burden and refinancing.
Earnings
- Next earnings
- 3 Feb 2027in 82 days
- Last reported
- 2 Nov 2026EPS reported $0.16 (expected $0.16)below expectations
Analyst estimates
Earnings estimates have barely changed since 24 Oct 2026.
- Earnings per share
- $0.450.0%
- Revenue
- $15.44B0.0%
- Earnings per share
- $0.380.0%
- Revenue
- $15.74B0.0%
MEQIRI has stored the estimates since 24 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
What happened at Sumitomo Chemical
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
461 rated companies in Basic Materials
- This company
- 54
- Sector median
- 57
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Chemicals (Specialty)
The next larger and next smaller companies by market value
- Hubei Feilihua Quartz Glass300395.SZ $5.62B55
- Gujarat FluorochemicalsFLUOROCHEM.NS $5.62B59
- BalchemBCPC $5.49B72
- Navin Fluorine InternationalNAVINFLUOR.NS $5.44B79
- Zhejiang Longsheng Group600352.SS $5.38B55
- Xinjiang Daqo New Energy688303.SS $5.37B32
- LB Group002601.SZ $5.33B45
- ArkemaAKE.PA $4.99B50
ETFs that hold Sumitomo Chemical
Held by 32 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| iShares MSCI Japan Small Cap UCITS ETFIUS4 | 0.36% | 0.58% | €548.59M |
| WisdomTree Japan Equity UCITS ETF EUR Hedged AccWTIF | 0.13% | 0.45% | €892.19M |
| Vanguard FTSE Japan UCITS ETF EUR Hedged AccumulatingVJPE | 0.09% | 0.13% | €4.58B |
Show 5 more
| Amundi Prime Japan UCITS ETF DR (C)PRAJ | 0.08% | 0.05% | €4.34B |
| Amundi Japan TOPIX II UCITS ETF EUR Hedged DistJPNH | 0.08% | 0.45% | €633.4M |
| iShares Core MSCI Japan IMI UCITS ETFEUNN | 0.08% | 0.12% | €7.17B |
| State Street SPDR MSCI World Small Cap UCITS ETF (Acc)ZPRS | 0.05% | 0.45% | €1.54B |
| Invesco RAFI All-World Fundamental Value UCITS ETFPSWD | 0.03% | 0.39% | €452.87M |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2026, period end 31 Mar 2026
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = ¥159.70)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 2 Jan 2026)
- Valuation signal Undervalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.